Community-acquired pneumonia due to drug-resistant Enterobacteriaceae: A global perspective
- PMID: 31645083
- DOI: 10.1111/resp.13720
Community-acquired pneumonia due to drug-resistant Enterobacteriaceae: A global perspective
Keywords: Enterobacteriaceae; community-acquired pneumonia; multidrug resistance.
Comment on
-
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.Respirology. 2020 May;25(5):543-551. doi: 10.1111/resp.13663. Epub 2019 Aug 5. Respirology. 2020. PMID: 31385399
References
REFERENCES
-
- Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2013; 188: 985-95.
-
- Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44(Suppl. 2): S27-72.
-
- Falguera M, Carratala J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, Gudiol F, Porcel JM. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology 2009; 14: 105-11.
-
- Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur. Respir. J. 2011; 38: 878-87.
-
- Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, Goossens H; Global-PPS Network. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob. Health 2018; 6: e619-e29.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
